The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Flunixin Meglumine Injection Market Research Report 2024
Synopsis
Flunixin Meglumine Injection is used for febrile diseases, muscle pain and soft tissue pain of livestock and small animals
The global Flunixin Meglumine Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Flunixin Meglumine Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Flunixin Meglumine Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Flunixin Meglumine Injection include Norbrook, Zoteis, Merck Animal Health, Virbac Animal Health India Private Limited, MSD Animal Health, Bengal Remedies Limited, Wuhan Huisheng Biological Technology Co., Ltd., Qilu Animal Health Products Co., Ltd. and Baimukang Animal Pharmaceutical Co., Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Flunixin Meglumine Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Flunixin Meglumine Injection.
Report Scope
The Flunixin Meglumine Injection market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Flunixin Meglumine Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Flunixin Meglumine Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Norbrook
Zoteis
Merck Animal Health
Virbac Animal Health India Private Limited
MSD Animal Health
Bengal Remedies Limited
Wuhan Huisheng Biological Technology Co., Ltd.
Qilu Animal Health Products Co., Ltd.
Baimukang Animal Pharmaceutical Co., Ltd.
Shandong Zhongmu Veterinary Medicine Co., Ltd.
Hebei New Century Pharmaceutical Co., Ltd.
Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd.
Shandong Lukang Pharmaceutical Co., Ltd.
Segment by Type
10ml/Dose
20ml/ Dose
Segment by Application
Animal muscle pain
Animal febrile disease
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Flunixin Meglumine Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Flunixin Meglumine Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Flunixin Meglumine Injection is used for febrile diseases, muscle pain and soft tissue pain of livestock and small animals
The global Flunixin Meglumine Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Flunixin Meglumine Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Flunixin Meglumine Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Flunixin Meglumine Injection include Norbrook, Zoteis, Merck Animal Health, Virbac Animal Health India Private Limited, MSD Animal Health, Bengal Remedies Limited, Wuhan Huisheng Biological Technology Co., Ltd., Qilu Animal Health Products Co., Ltd. and Baimukang Animal Pharmaceutical Co., Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Flunixin Meglumine Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Flunixin Meglumine Injection.
Report Scope
The Flunixin Meglumine Injection market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Flunixin Meglumine Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Flunixin Meglumine Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Norbrook
Zoteis
Merck Animal Health
Virbac Animal Health India Private Limited
MSD Animal Health
Bengal Remedies Limited
Wuhan Huisheng Biological Technology Co., Ltd.
Qilu Animal Health Products Co., Ltd.
Baimukang Animal Pharmaceutical Co., Ltd.
Shandong Zhongmu Veterinary Medicine Co., Ltd.
Hebei New Century Pharmaceutical Co., Ltd.
Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd.
Shandong Lukang Pharmaceutical Co., Ltd.
Segment by Type
10ml/Dose
20ml/ Dose
Segment by Application
Animal muscle pain
Animal febrile disease
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Flunixin Meglumine Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Flunixin Meglumine Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Flunixin Meglumine Injection Market Overview
1.1 Product Overview and Scope of Flunixin Meglumine Injection
1.2 Flunixin Meglumine Injection Segment by Type
1.2.1 Global Flunixin Meglumine Injection Market Value Comparison by Type (2024-2030)
1.2.2 10ml/Dose
1.2.3 20ml/ Dose
1.3 Flunixin Meglumine Injection Segment by Application
1.3.1 Global Flunixin Meglumine Injection Market Value by Application: (2024-2030)
1.3.2 Animal muscle pain
1.3.3 Animal febrile disease
1.3.4 Others
1.4 Global Flunixin Meglumine Injection Market Size Estimates and Forecasts
1.4.1 Global Flunixin Meglumine Injection Revenue 2019-2030
1.4.2 Global Flunixin Meglumine Injection Sales 2019-2030
1.4.3 Global Flunixin Meglumine Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Flunixin Meglumine Injection Market Competition by Manufacturers
2.1 Global Flunixin Meglumine Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Flunixin Meglumine Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Flunixin Meglumine Injection Average Price by Manufacturers (2019-2024)
2.4 Global Flunixin Meglumine Injection Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Flunixin Meglumine Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Flunixin Meglumine Injection, Product Type & Application
2.7 Flunixin Meglumine Injection Market Competitive Situation and Trends
2.7.1 Flunixin Meglumine Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Flunixin Meglumine Injection Players Market Share by Revenue
2.7.3 Global Flunixin Meglumine Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Flunixin Meglumine Injection Retrospective Market Scenario by Region
3.1 Global Flunixin Meglumine Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Flunixin Meglumine Injection Global Flunixin Meglumine Injection Sales by Region: 2019-2030
3.2.1 Global Flunixin Meglumine Injection Sales by Region: 2019-2024
3.2.2 Global Flunixin Meglumine Injection Sales by Region: 2025-2030
3.3 Global Flunixin Meglumine Injection Global Flunixin Meglumine Injection Revenue by Region: 2019-2030
3.3.1 Global Flunixin Meglumine Injection Revenue by Region: 2019-2024
3.3.2 Global Flunixin Meglumine Injection Revenue by Region: 2025-2030
3.4 North America Flunixin Meglumine Injection Market Facts & Figures by Country
3.4.1 North America Flunixin Meglumine Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Flunixin Meglumine Injection Sales by Country (2019-2030)
3.4.3 North America Flunixin Meglumine Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Flunixin Meglumine Injection Market Facts & Figures by Country
3.5.1 Europe Flunixin Meglumine Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Flunixin Meglumine Injection Sales by Country (2019-2030)
3.5.3 Europe Flunixin Meglumine Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Flunixin Meglumine Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Flunixin Meglumine Injection Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Flunixin Meglumine Injection Sales by Country (2019-2030)
3.6.3 Asia Pacific Flunixin Meglumine Injection Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Flunixin Meglumine Injection Market Facts & Figures by Country
3.7.1 Latin America Flunixin Meglumine Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Flunixin Meglumine Injection Sales by Country (2019-2030)
3.7.3 Latin America Flunixin Meglumine Injection Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Flunixin Meglumine Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Flunixin Meglumine Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Flunixin Meglumine Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Flunixin Meglumine Injection Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Flunixin Meglumine Injection Sales by Type (2019-2030)
4.1.1 Global Flunixin Meglumine Injection Sales by Type (2019-2024)
4.1.2 Global Flunixin Meglumine Injection Sales by Type (2025-2030)
4.1.3 Global Flunixin Meglumine Injection Sales Market Share by Type (2019-2030)
4.2 Global Flunixin Meglumine Injection Revenue by Type (2019-2030)
4.2.1 Global Flunixin Meglumine Injection Revenue by Type (2019-2024)
4.2.2 Global Flunixin Meglumine Injection Revenue by Type (2025-2030)
4.2.3 Global Flunixin Meglumine Injection Revenue Market Share by Type (2019-2030)
4.3 Global Flunixin Meglumine Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Flunixin Meglumine Injection Sales by Application (2019-2030)
5.1.1 Global Flunixin Meglumine Injection Sales by Application (2019-2024)
5.1.2 Global Flunixin Meglumine Injection Sales by Application (2025-2030)
5.1.3 Global Flunixin Meglumine Injection Sales Market Share by Application (2019-2030)
5.2 Global Flunixin Meglumine Injection Revenue by Application (2019-2030)
5.2.1 Global Flunixin Meglumine Injection Revenue by Application (2019-2024)
5.2.2 Global Flunixin Meglumine Injection Revenue by Application (2025-2030)
5.2.3 Global Flunixin Meglumine Injection Revenue Market Share by Application (2019-2030)
5.3 Global Flunixin Meglumine Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Norbrook
6.1.1 Norbrook Corporation Information
6.1.2 Norbrook Description and Business Overview
6.1.3 Norbrook Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Norbrook Flunixin Meglumine Injection Product Portfolio
6.1.5 Norbrook Recent Developments/Updates
6.2 Zoteis
6.2.1 Zoteis Corporation Information
6.2.2 Zoteis Description and Business Overview
6.2.3 Zoteis Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Zoteis Flunixin Meglumine Injection Product Portfolio
6.2.5 Zoteis Recent Developments/Updates
6.3 Merck Animal Health
6.3.1 Merck Animal Health Corporation Information
6.3.2 Merck Animal Health Description and Business Overview
6.3.3 Merck Animal Health Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Animal Health Flunixin Meglumine Injection Product Portfolio
6.3.5 Merck Animal Health Recent Developments/Updates
6.4 Virbac Animal Health India Private Limited
6.4.1 Virbac Animal Health India Private Limited Corporation Information
6.4.2 Virbac Animal Health India Private Limited Description and Business Overview
6.4.3 Virbac Animal Health India Private Limited Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Virbac Animal Health India Private Limited Flunixin Meglumine Injection Product Portfolio
6.4.5 Virbac Animal Health India Private Limited Recent Developments/Updates
6.5 MSD Animal Health
6.5.1 MSD Animal Health Corporation Information
6.5.2 MSD Animal Health Description and Business Overview
6.5.3 MSD Animal Health Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 MSD Animal Health Flunixin Meglumine Injection Product Portfolio
6.5.5 MSD Animal Health Recent Developments/Updates
6.6 Bengal Remedies Limited
6.6.1 Bengal Remedies Limited Corporation Information
6.6.2 Bengal Remedies Limited Description and Business Overview
6.6.3 Bengal Remedies Limited Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Bengal Remedies Limited Flunixin Meglumine Injection Product Portfolio
6.6.5 Bengal Remedies Limited Recent Developments/Updates
6.7 Wuhan Huisheng Biological Technology Co., Ltd.
6.6.1 Wuhan Huisheng Biological Technology Co., Ltd. Corporation Information
6.6.2 Wuhan Huisheng Biological Technology Co., Ltd. Description and Business Overview
6.6.3 Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Product Portfolio
6.7.5 Wuhan Huisheng Biological Technology Co., Ltd. Recent Developments/Updates
6.8 Qilu Animal Health Products Co., Ltd.
6.8.1 Qilu Animal Health Products Co., Ltd. Corporation Information
6.8.2 Qilu Animal Health Products Co., Ltd. Description and Business Overview
6.8.3 Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Product Portfolio
6.8.5 Qilu Animal Health Products Co., Ltd. Recent Developments/Updates
6.9 Baimukang Animal Pharmaceutical Co., Ltd.
6.9.1 Baimukang Animal Pharmaceutical Co., Ltd. Corporation Information
6.9.2 Baimukang Animal Pharmaceutical Co., Ltd. Description and Business Overview
6.9.3 Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Portfolio
6.9.5 Baimukang Animal Pharmaceutical Co., Ltd. Recent Developments/Updates
6.10 Shandong Zhongmu Veterinary Medicine Co., Ltd.
6.10.1 Shandong Zhongmu Veterinary Medicine Co., Ltd. Corporation Information
6.10.2 Shandong Zhongmu Veterinary Medicine Co., Ltd. Description and Business Overview
6.10.3 Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Product Portfolio
6.10.5 Shandong Zhongmu Veterinary Medicine Co., Ltd. Recent Developments/Updates
6.11 Hebei New Century Pharmaceutical Co., Ltd.
6.11.1 Hebei New Century Pharmaceutical Co., Ltd. Corporation Information
6.11.2 Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Description and Business Overview
6.11.3 Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Portfolio
6.11.5 Hebei New Century Pharmaceutical Co., Ltd. Recent Developments/Updates
6.12 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd.
6.12.1 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Corporation Information
6.12.2 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Description and Business Overview
6.12.3 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Portfolio
6.12.5 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Recent Developments/Updates
6.13 Shandong Lukang Pharmaceutical Co., Ltd.
6.13.1 Shandong Lukang Pharmaceutical Co., Ltd. Corporation Information
6.13.2 Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Description and Business Overview
6.13.3 Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Portfolio
6.13.5 Shandong Lukang Pharmaceutical Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Flunixin Meglumine Injection Industry Chain Analysis
7.2 Flunixin Meglumine Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Flunixin Meglumine Injection Production Mode & Process
7.4 Flunixin Meglumine Injection Sales and Marketing
7.4.1 Flunixin Meglumine Injection Sales Channels
7.4.2 Flunixin Meglumine Injection Distributors
7.5 Flunixin Meglumine Injection Customers
8 Flunixin Meglumine Injection Market Dynamics
8.1 Flunixin Meglumine Injection Industry Trends
8.2 Flunixin Meglumine Injection Market Drivers
8.3 Flunixin Meglumine Injection Market Challenges
8.4 Flunixin Meglumine Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Flunixin Meglumine Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Flunixin Meglumine Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Flunixin Meglumine Injection Market Competitive Situation by Manufacturers in 2023
Table 4. Global Flunixin Meglumine Injection Sales (K Doses) of Key Manufacturers (2019-2024)
Table 5. Global Flunixin Meglumine Injection Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Flunixin Meglumine Injection Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Flunixin Meglumine Injection Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Flunixin Meglumine Injection Average Price (US$/Dose) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Flunixin Meglumine Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Flunixin Meglumine Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Flunixin Meglumine Injection, Product Type & Application
Table 12. Global Key Manufacturers of Flunixin Meglumine Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Flunixin Meglumine Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Flunixin Meglumine Injection as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Flunixin Meglumine Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Flunixin Meglumine Injection Sales by Region (2019-2024) & (K Doses)
Table 18. Global Flunixin Meglumine Injection Sales Market Share by Region (2019-2024)
Table 19. Global Flunixin Meglumine Injection Sales by Region (2025-2030) & (K Doses)
Table 20. Global Flunixin Meglumine Injection Sales Market Share by Region (2025-2030)
Table 21. Global Flunixin Meglumine Injection Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Flunixin Meglumine Injection Revenue Market Share by Region (2019-2024)
Table 23. Global Flunixin Meglumine Injection Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Flunixin Meglumine Injection Revenue Market Share by Region (2025-2030)
Table 25. North America Flunixin Meglumine Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Flunixin Meglumine Injection Sales by Country (2019-2024) & (K Doses)
Table 27. North America Flunixin Meglumine Injection Sales by Country (2025-2030) & (K Doses)
Table 28. North America Flunixin Meglumine Injection Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Flunixin Meglumine Injection Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Flunixin Meglumine Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Flunixin Meglumine Injection Sales by Country (2019-2024) & (K Doses)
Table 32. Europe Flunixin Meglumine Injection Sales by Country (2025-2030) & (K Doses)
Table 33. Europe Flunixin Meglumine Injection Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Flunixin Meglumine Injection Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Flunixin Meglumine Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Flunixin Meglumine Injection Sales by Region (2019-2024) & (K Doses)
Table 37. Asia Pacific Flunixin Meglumine Injection Sales by Region (2025-2030) & (K Doses)
Table 38. Asia Pacific Flunixin Meglumine Injection Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Flunixin Meglumine Injection Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Flunixin Meglumine Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Flunixin Meglumine Injection Sales by Country (2019-2024) & (K Doses)
Table 42. Latin America Flunixin Meglumine Injection Sales by Country (2025-2030) & (K Doses)
Table 43. Latin America Flunixin Meglumine Injection Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Flunixin Meglumine Injection Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Flunixin Meglumine Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Flunixin Meglumine Injection Sales by Country (2019-2024) & (K Doses)
Table 47. Middle East & Africa Flunixin Meglumine Injection Sales by Country (2025-2030) & (K Doses)
Table 48. Middle East & Africa Flunixin Meglumine Injection Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Flunixin Meglumine Injection Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Flunixin Meglumine Injection Sales (K Doses) by Type (2019-2024)
Table 51. Global Flunixin Meglumine Injection Sales (K Doses) by Type (2025-2030)
Table 52. Global Flunixin Meglumine Injection Sales Market Share by Type (2019-2024)
Table 53. Global Flunixin Meglumine Injection Sales Market Share by Type (2025-2030)
Table 54. Global Flunixin Meglumine Injection Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Flunixin Meglumine Injection Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Flunixin Meglumine Injection Revenue Market Share by Type (2019-2024)
Table 57. Global Flunixin Meglumine Injection Revenue Market Share by Type (2025-2030)
Table 58. Global Flunixin Meglumine Injection Price (US$/Dose) by Type (2019-2024)
Table 59. Global Flunixin Meglumine Injection Price (US$/Dose) by Type (2025-2030)
Table 60. Global Flunixin Meglumine Injection Sales (K Doses) by Application (2019-2024)
Table 61. Global Flunixin Meglumine Injection Sales (K Doses) by Application (2025-2030)
Table 62. Global Flunixin Meglumine Injection Sales Market Share by Application (2019-2024)
Table 63. Global Flunixin Meglumine Injection Sales Market Share by Application (2025-2030)
Table 64. Global Flunixin Meglumine Injection Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Flunixin Meglumine Injection Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Flunixin Meglumine Injection Revenue Market Share by Application (2019-2024)
Table 67. Global Flunixin Meglumine Injection Revenue Market Share by Application (2025-2030)
Table 68. Global Flunixin Meglumine Injection Price (US$/Dose) by Application (2019-2024)
Table 69. Global Flunixin Meglumine Injection Price (US$/Dose) by Application (2025-2030)
Table 70. Norbrook Corporation Information
Table 71. Norbrook Description and Business Overview
Table 72. Norbrook Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 73. Norbrook Flunixin Meglumine Injection Product
Table 74. Norbrook Recent Developments/Updates
Table 75. Zoteis Corporation Information
Table 76. Zoteis Description and Business Overview
Table 77. Zoteis Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 78. Zoteis Flunixin Meglumine Injection Product
Table 79. Zoteis Recent Developments/Updates
Table 80. Merck Animal Health Corporation Information
Table 81. Merck Animal Health Description and Business Overview
Table 82. Merck Animal Health Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 83. Merck Animal Health Flunixin Meglumine Injection Product
Table 84. Merck Animal Health Recent Developments/Updates
Table 85. Virbac Animal Health India Private Limited Corporation Information
Table 86. Virbac Animal Health India Private Limited Description and Business Overview
Table 87. Virbac Animal Health India Private Limited Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 88. Virbac Animal Health India Private Limited Flunixin Meglumine Injection Product
Table 89. Virbac Animal Health India Private Limited Recent Developments/Updates
Table 90. MSD Animal Health Corporation Information
Table 91. MSD Animal Health Description and Business Overview
Table 92. MSD Animal Health Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 93. MSD Animal Health Flunixin Meglumine Injection Product
Table 94. MSD Animal Health Recent Developments/Updates
Table 95. Bengal Remedies Limited Corporation Information
Table 96. Bengal Remedies Limited Description and Business Overview
Table 97. Bengal Remedies Limited Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 98. Bengal Remedies Limited Flunixin Meglumine Injection Product
Table 99. Bengal Remedies Limited Recent Developments/Updates
Table 100. Wuhan Huisheng Biological Technology Co., Ltd. Corporation Information
Table 101. Wuhan Huisheng Biological Technology Co., Ltd. Description and Business Overview
Table 102. Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 103. Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Product
Table 104. Wuhan Huisheng Biological Technology Co., Ltd. Recent Developments/Updates
Table 105. Qilu Animal Health Products Co., Ltd. Corporation Information
Table 106. Qilu Animal Health Products Co., Ltd. Description and Business Overview
Table 107. Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 108. Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Product
Table 109. Qilu Animal Health Products Co., Ltd. Recent Developments/Updates
Table 110. Baimukang Animal Pharmaceutical Co., Ltd. Corporation Information
Table 111. Baimukang Animal Pharmaceutical Co., Ltd. Description and Business Overview
Table 112. Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 113. Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product
Table 114. Baimukang Animal Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 115. Shandong Zhongmu Veterinary Medicine Co., Ltd. Corporation Information
Table 116. Shandong Zhongmu Veterinary Medicine Co., Ltd. Description and Business Overview
Table 117. Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 118. Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Product
Table 119. Shandong Zhongmu Veterinary Medicine Co., Ltd. Recent Developments/Updates
Table 120. Hebei New Century Pharmaceutical Co., Ltd. Corporation Information
Table 121. Hebei New Century Pharmaceutical Co., Ltd. Description and Business Overview
Table 122. Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 123. Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product
Table 124. Hebei New Century Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 125. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Corporation Information
Table 126. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Description and Business Overview
Table 127. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 128. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product
Table 129. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 130. Shandong Lukang Pharmaceutical Co., Ltd. Corporation Information
Table 131. Shandong Lukang Pharmaceutical Co., Ltd. Description and Business Overview
Table 132. Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 133. Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product
Table 134. Shandong Lukang Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Flunixin Meglumine Injection Distributors List
Table 138. Flunixin Meglumine Injection Customers List
Table 139. Flunixin Meglumine Injection Market Trends
Table 140. Flunixin Meglumine Injection Market Drivers
Table 141. Flunixin Meglumine Injection Market Challenges
Table 142. Flunixin Meglumine Injection Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Flunixin Meglumine Injection
Figure 2. Global Flunixin Meglumine Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Flunixin Meglumine Injection Market Share by Type in 2023 & 2030
Figure 4. 10ml/Dose Product Picture
Figure 5. 20ml/ Dose Product Picture
Figure 6. Global Flunixin Meglumine Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Flunixin Meglumine Injection Market Share by Application in 2023 & 2030
Figure 8. Animal muscle pain
Figure 9. Animal febrile disease
Figure 10. Others
Figure 11. Global Flunixin Meglumine Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Flunixin Meglumine Injection Market Size (2019-2030) & (US$ Million)
Figure 13. Global Flunixin Meglumine Injection Sales (2019-2030) & (K Doses)
Figure 14. Global Flunixin Meglumine Injection Average Price (US$/Dose) & (2019-2030)
Figure 15. Flunixin Meglumine Injection Report Years Considered
Figure 16. Flunixin Meglumine Injection Sales Share by Manufacturers in 2023
Figure 17. Global Flunixin Meglumine Injection Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Flunixin Meglumine Injection Players: Market Share by Revenue in 2023
Figure 19. Flunixin Meglumine Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Flunixin Meglumine Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Flunixin Meglumine Injection Sales Market Share by Country (2019-2030)
Figure 22. North America Flunixin Meglumine Injection Revenue Market Share by Country (2019-2030)
Figure 23. United States Flunixin Meglumine Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Flunixin Meglumine Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Flunixin Meglumine Injection Sales Market Share by Country (2019-2030)
Figure 26. Europe Flunixin Meglumine Injection Revenue Market Share by Country (2019-2030)
Figure 27. Germany Flunixin Meglumine Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Flunixin Meglumine Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Flunixin Meglumine Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Flunixin Meglumine Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Flunixin Meglumine Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Flunixin Meglumine Injection Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Flunixin Meglumine Injection Revenue Market Share by Region (2019-2030)
Figure 34. China Flunixin Meglumine Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Flunixin Meglumine Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Flunixin Meglumine Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Flunixin Meglumine Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Flunixin Meglumine Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Flunixin Meglumine Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Flunixin Meglumine Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Flunixin Meglumine Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Flunixin Meglumine Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Flunixin Meglumine Injection Sales Market Share by Country (2019-2030)
Figure 44. Latin America Flunixin Meglumine Injection Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Flunixin Meglumine Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Flunixin Meglumine Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Flunixin Meglumine Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Flunixin Meglumine Injection Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Flunixin Meglumine Injection Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Flunixin Meglumine Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Flunixin Meglumine Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Flunixin Meglumine Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Flunixin Meglumine Injection by Type (2019-2030)
Figure 54. Global Revenue Market Share of Flunixin Meglumine Injection by Type (2019-2030)
Figure 55. Global Flunixin Meglumine Injection Price (US$/Dose) by Type (2019-2030)
Figure 56. Global Sales Market Share of Flunixin Meglumine Injection by Application (2019-2030)
Figure 57. Global Revenue Market Share of Flunixin Meglumine Injection by Application (2019-2030)
Figure 58. Global Flunixin Meglumine Injection Price (US$/Dose) by Application (2019-2030)
Figure 59. Flunixin Meglumine Injection Value Chain
Figure 60. Flunixin Meglumine Injection Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
